Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01279616
What this trial is testing

A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Nationwide Children's Hospital 8
Testing effectiveness (Phase 2)Study completedNCT00504634
What this trial is testing

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00737516
What this trial is testing

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
National Marrow Donor Program 3,621
Testing effectiveness (Phase 2)Study completedNCT01220895
What this trial is testing

Alternate Donor Study of Pre-Emptive Cellular Therapy

Who this might be right for
Cytomegalovirus Infection
Cell Medica Ltd 52
Large-scale testing (Phase 3)Study completedNCT05149365
What this trial is testing

Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation

Who this might be right for
Acute-graft-versus-host DiseaseAllogeneic Hematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 190
Not applicableNot Yet RecruitingNCT07010068
What this trial is testing

Nutritional Support With TGF-β2 Food for Special Medical Purposes (TGF-β2 FSMP) in Adult Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) for the Prevention of Malnutrition: a Prospective, Randomized, Multicenter Study

Who this might be right for
Malnutrition (Calorie)Stem Cell Transplant Complications
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 214
Very early researchLooking for participantsNCT06735690
What this trial is testing

Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
City of Hope Medical Center 15
Large-scale testing (Phase 3)Study completedNCT05763823
What this trial is testing

Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)

Who this might be right for
Cytomegalovirus Infection
Merck Sharp & Dohme LLC 120
Testing effectiveness (Phase 2)WithdrawnNCT02724904
What this trial is testing

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma

Who this might be right for
Lymphoma
Massachusetts General Hospital
Not applicableStudy completedNCT07150468
What this trial is testing

Establishment of a Strategy for Preventing Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation by Exploring Immune Mechanisms of Regulatory and Effector T Cells

Who this might be right for
Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasms, Lymphoma, Multiple Myeloma
Asan Medical Center 146
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07552649
What this trial is testing

Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia

Who this might be right for
AML (Acute Myeloid Leukemia)
Antonio Pierini 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098313
What this trial is testing

HCT With PTCy in Higher-risk MDS

Who this might be right for
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
Asan Medical Center 113
Testing effectiveness (Phase 2)UnknownNCT00750126
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Solid TumorsHematologic Neoplasms
University Hospital, Clermont-Ferrand 30
Large-scale testing (Phase 3)Study completedNCT01503515
What this trial is testing

Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant

Who this might be right for
Fungal InfectionHematopoietic and Lymphoid Cell Neoplasm
Children's Oncology Group 292
Testing effectiveness (Phase 2)UnknownNCT04593368
What this trial is testing

Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Antibiotic Resistant Strain
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03663933
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

Who this might be right for
Lymphoproliferative DisordersAutoimmune LymphoproliferativePrimary T-cell Immunodeficiency Disorders+2 more
National Cancer Institute (NCI) 71
Not applicableStudy completedNCT04469985
What this trial is testing

Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO Survey

Who this might be right for
Allogeneic Stem Cell Transplantation in Elderly Patients
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2,061
Not applicableUnknownNCT00563108
What this trial is testing

Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Hospital Authority, Hong Kong 60
Testing effectiveness (Phase 2)Ended earlyNCT04205240
What this trial is testing

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Srinivas Devarakonda 1
Next Page
35